Trademark: 98251414
Word
SPYRE THERAPEUTICS
Status
Pending
Status Code
661
Status Date
Thursday, September 19, 2024
Serial Number
98251414
Mark Type
3
Filing Date
Thursday, November 2, 2023

Trademark Owner History
SPYRE THERAPEUTICS, INC. - 1st New Owner Before Publication
Aeglea BioTherapeutics, Inc. - Original Applicant

Classifications
5 Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders and immune system related diseases and disorders
The mark consists of a stylized three-prong antibody design above the word "SPYRE" in all capital letters which is above the word "THERAPEUTICS" in smaller capital letters.
Color is not claimed as a feature of the mark.

Trademark Events
Nov 6, 2023
New Application Entered
Nov 17, 2023
New Application Office Supplied Data Entered
Nov 18, 2023
Notice Of Design Search Code E-Mailed
May 16, 2024
Automatic Update Of Assignment Of Ownership
Jun 13, 2024
Non-Final Action Written
Jun 13, 2024
Notification Of Non-Final Action E-Mailed
Jun 13, 2024
Non-Final Action E-Mailed
Jun 13, 2024
Assigned To Examiner
Sep 3, 2024
Application Extension Granted/Receipt Provided
Sep 3, 2024
Application Extension To Response Period - Received
Sep 19, 2024
Teas/Email Correspondence Entered
Sep 19, 2024
Correspondence Received In Law Office
Sep 19, 2024
Teas Response To Office Action Received

Trademark Alertz updated from USPTO on 2030-01-24